ProShare Advisors
NAUT icon

ProShare Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History

ProShare Advisors’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,546
Closed -$9.08K – 2146
2025
Q1 		$9.08K Sell
10,546
-3,175
-23% -$4.72K ﹤0.01% 2070
2024
Q4 		$23.1K Sell
13,721
-2,895
-17% -$6.92K ﹤0.01% 2252
2024
Q3 		$47.4K Buy
16,616
+2,122
+15% +$5.49K ﹤0.01% 1986
2024
Q2 		$33.9K Sell
14,494
-3,344
-19% -$8.73K ﹤0.01% 1782
2024
Q1 		$52.4K Buy
17,838
+1,497
+9% +$4.25K ﹤0.01% 1898
2023
Q4 		$48.9K Buy
16,341
+1,615
+11% +$4.62K ﹤0.01% 1864
2023
Q3 		$46.5K Buy
14,726
+80
+0.5% +$260 ﹤0.01% 1722
2023
Q2 		$56.7K Buy
14,646
+378
+3% +$1.09K ﹤0.01% 1759
2023
Q1 		$39.5K Sell
14,268
-2,181
-13% -$4.58K ﹤0.01% 1690
2022
Q4 		$29.6K Buy
16,449
+709
+5% +$1.37K ﹤0.01% 1785
2022
Q3 		$33K Buy
15,740
+691
+5% +$1.74K ﹤0.01% 1694
2022
Q2 		$40K Buy
15,049
+2,172
+17% +$8.08K ﹤0.01% 1728
2022
Q1 		$56K Sell
12,877
-4,608
-26% -$18.9K ﹤0.01% 2107
2021
Q4 		$91K Buy
+17,485
New +$93.6K ﹤0.01% 2217

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

ProShare Advisors's NAUT Position: Q2 2025 in Review

ProShare Advisors sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 10,546 shares — an estimated $9.08K sold.

ProShare Advisors first reported a position in NAUT in Q4 2021 and held it in 14 quarters. The position peaked at $91K in Q4 2021. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • ProShare Advisors reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • ProShare Advisors sold 10,546 Nautilus Biotechnolgy shares in Q2 2025, an estimated $9.08K.
  • ProShare Advisors first reported a position in Nautilus Biotechnolgy in Q4 2021 and held it in 14 quarters.
  • ProShare Advisors's Nautilus Biotechnolgy position peaked at $91K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on ProShare Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.